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Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, characterized by upper and lower motor neuron degeneration. Glutamate(Glu)-mediated excitotoxicity plays a major role in cell death and Glu has been 
found elevated in serum of patients and animal models of ALS. The aim of this research was to investigate whether 
the augmentend extracellular Glu can be sustainend by alteration of its release. Glu release was studied from purified 
spinal cord synaptosomes of SOD1G93A mice at the early and the late phases of the disease (4 and 17 weeks of 
life, respectively). Both the spontaneous and the stimulus-evoked exocytotic Glu release were increased at the two 
stages studied. We also measured the expression/activation state of a number of pre-synaptic proteins involved in 
neurotransmitter release: few of them were found modified and synaptotagmin and actin resulted over-expressed in 
both 4 and 17 week-old mice. Increased pre-synaptic Ca2+ levels, over-activation of calcium/calmodulin-dependent 
kinase-II and ERK/MAP kinases correlate with hyper-phosphorylation of synapsin-I at both stages. In line with 
these findings, Glu exocytosis was paralleled by the increase of the readily releasable pool of vesicles and prevented 
by blocking synapsin-I phosphorylation, using specific antibodies. Our results highlight that abnormal glutamate 
release is present in the spinal cord of SOD1G93A mice at the pre-symptomatic and late stage of the disease, an event 
accompanied by marked plastic changes of specific pre-synaptic mechanisms supporting exocytosis, that in turn 
may represent targets to diminish exitotoxicity in ALS. The precociousness of this phenomenon may imply that it 
represents a cause rather than a consequence of the neuronal damage during disease progression.
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